Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Corey

Showing results (381-390 of 551) with videos related to

Pageof 56
Sort By:
Journal of Virology|October 19, 2018
Acute Infection and Subsequent Subclinical Reactivation of Herpes Simplex Virus 2 after Vaginal Inoculation of Rhesus MacaquesMing Lo, Jia Zhu, Scott G Hansen, et al.
Virology|March 4, 2008
Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B virusesYi Liu, Marcel E Curlin, Kurt Diem, et al.
The Journal of Infectious Diseases|December 25, 2024
Pre-Human Immunodeficiency Virus (HIV) α4β7hi CD4+ T Cells and HIV Risk Among Heterosexual Individuals in AfricaTosin E Omole, Huong Mai Nguyen, Agata Marcinow, et al.
Open Forum Infectious Diseases|February 21, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster VaccineTara M Babu, Xiaoying Shen, R Scott McClelland, et al.
Lancet (London, England)|November 18, 2008
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialSusan P Buchbinder, Devan V Mehrotra, Ann Duerr, et al.
Vaccine|October 11, 2005
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjectsGuy de Bruyn, Mauricio Vargas-Cortez, Terri Warren, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2002
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022AKalpana Gupta, Michael Hudgens, Lawrence Corey, et al.
The Journal of Infectious Diseases|August 6, 2004
Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutantsJohn P DeVincenzo, Caroline B Hall, David W Kimberlin, et al.
The Journal of Infectious Diseases|September 30, 2025
Respiratory Virus Infections and Pulmonary Impairment after Allogeneic Hematopoietic Cell TransplantationGuang-Shing Cheng, Angela P Campbell, Hu Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2019
Human Herpesvirus 6B and Lower Respiratory Tract Disease After Hematopoietic Cell TransplantationJoshua A Hill, Lisa K Vande Vusse, Hu Xie, et al.
Pageof 56

Showing results (381-390 of 551) with videos related to

Sort By:
Pageof 56
Journal of Virology|October 19, 2018
Acute Infection and Subsequent Subclinical Reactivation of Herpes Simplex Virus 2 after Vaginal Inoculation of Rhesus MacaquesMing Lo, Jia Zhu, Scott G Hansen, et al.
Virology|March 4, 2008
Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B virusesYi Liu, Marcel E Curlin, Kurt Diem, et al.
The Journal of Infectious Diseases|December 25, 2024
Pre-Human Immunodeficiency Virus (HIV) α4β7hi CD4+ T Cells and HIV Risk Among Heterosexual Individuals in AfricaTosin E Omole, Huong Mai Nguyen, Agata Marcinow, et al.
Open Forum Infectious Diseases|February 21, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster VaccineTara M Babu, Xiaoying Shen, R Scott McClelland, et al.
Lancet (London, England)|November 18, 2008
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialSusan P Buchbinder, Devan V Mehrotra, Ann Duerr, et al.
Vaccine|October 11, 2005
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjectsGuy de Bruyn, Mauricio Vargas-Cortez, Terri Warren, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2002
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022AKalpana Gupta, Michael Hudgens, Lawrence Corey, et al.
The Journal of Infectious Diseases|August 6, 2004
Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutantsJohn P DeVincenzo, Caroline B Hall, David W Kimberlin, et al.
The Journal of Infectious Diseases|September 30, 2025
Respiratory Virus Infections and Pulmonary Impairment after Allogeneic Hematopoietic Cell TransplantationGuang-Shing Cheng, Angela P Campbell, Hu Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2019
Human Herpesvirus 6B and Lower Respiratory Tract Disease After Hematopoietic Cell TransplantationJoshua A Hill, Lisa K Vande Vusse, Hu Xie, et al.
Pageof 56